Skip to content
10-Q

Quarterly Report

BIOCLINICA INC

0001104659-11-044927

← back to feed
Filed
Aug 8, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2011 · Jul 31, 2011 15.64M sh
Stockholders Equity Q2 2011 · Jun 30, 2011 $56.49M
Stockholders Equity Q2 2011 · Dec 31, 2010 $54.88M
Current Liabilities Q2 2011 · Jun 30, 2011 $23.27M
Current Liabilities Q2 2011 · Dec 31, 2010 $19.83M
Total Liabilities Q2 2011 · Jun 30, 2011 $28.09M
Total Liabilities Q2 2011 · Dec 31, 2010 $25.15M
Current Assets Q2 2011 · Jun 30, 2011 $32.22M
Current Assets Q2 2011 · Dec 31, 2010 $28.44M
Total Assets Q2 2011 · Jun 30, 2011 $84.58M
Total Assets Q2 2011 · Dec 31, 2010 $80.03M
Shares Diluted Q2 2011 · Jun 30, 2010 16.07M sh
Shares Diluted Q2 2011 · Jun 30, 2010 15.86M sh
Capex Q2 2011 · Jun 30, 2010 $2M
Operating Cash Flow Q2 2011 · Jun 30, 2010 $1.83M
Cash And Equivalents Q2 2011 · Jun 30, 2010 $11.57M
Cash And Equivalents Q2 2011 · Dec 31, 2009 $14.57M
Eps Diluted Q2 2011 · Jun 30, 2010 $0.03
Eps Diluted Q2 2011 · Jun 30, 2010 $0.07
Eps Basic Q2 2011 · Jun 30, 2010 $0.03
Eps Basic Q2 2011 · Jun 30, 2010 $0.08
Sga Expense Q2 2011 · Jun 30, 2010 $1.92M
Sga Expense Q2 2011 · Jun 30, 2010 $3.99M
Net Income Q2 2011 · Jun 30, 2010 $403K
Net Income Q2 2011 · Jun 30, 2010 $1.11M
Operating Income Q2 2011 · Jun 30, 2010 $657K
Operating Income Q2 2011 · Jun 30, 2010 $1.82M
Revenue Q2 2011 · Jun 30, 2010 $19.24M
Revenue Q2 2011 · Jun 30, 2010 $37.34M